Crime & Law · India
Supreme Court Questions Centre on Wider Medicine Price Controls
The Supreme Court of India questioned the central government on why price controls were being applied only to cancer drugs and not other medicines. The government had capped the trade margins on non-scheduled anti-cancer drugs at 30%. The court pressed the Centre to explain the rationale behind this selective approach, asking why other essential medicines were being left out of such price regulations.
How outlets across the spectrum covered it
L 0 C 3 R 0
- Centre (3): Deccan Herald, The Financial Express, The Hindu BusinessLine